Evaluation of a bromocresol purple method for the determination of albumin adapted to the DuPont aca discrete clinical analyzer

We evaluated a new method for the determination of albumin on the DuPont aca™ discrete clinical analyzer that utilized an albumin selective dye, bromocresol purple (BCP). This dye minimizes globulin interference that occurs with bromocresol green (BCG) methods that have long (>30 s) incubation ti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical biochemistry 1985-10, Vol.18 (5), p.290-296
Hauptverfasser: Lasky, Fred D., Li, Zol Mei C., Shaver, Douglas D., Savory, John, Savory, M. Geraldine, Willey, David G., Mikolak, Beverly J., Lantry, Cheryl L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We evaluated a new method for the determination of albumin on the DuPont aca™ discrete clinical analyzer that utilized an albumin selective dye, bromocresol purple (BCP). This dye minimizes globulin interference that occurs with bromocresol green (BCG) methods that have long (>30 s) incubation times. Good correlation was observed between the new BCP method and two methods which do not show significant globulin interference: an immunological method and a rapid BCG method. Comparisons with alternate BCG methods (SMA 12/60, SMAC, and the aca) were generally not as good. The albumin results by the BCP method on specimens with elevated globulins were similar to results from the immunological and rapid BCG methods. The reference interval was 34–50 g/L. The between-day coefficient of variation ranged from 0.9 to 3.5% at three evaluation sites on 2 levels of 8 different control materials. The method was linear between 6–70 g/L. No interference was observed from hemoglobin at levels ⩽5.00 g/L or from bilirubin at levels
ISSN:0009-9120
1873-2933
DOI:10.1016/S0009-9120(85)80034-5